At our 66,000 square foot, state-of-the-art laboratory located in Phoenix, Arizona, we provide high quality, reliable molecular testing services for all stages of the drug development cycle and routine clinical use. From pre-clinical research for compound development efforts to established, commercially available therapies, Caris provides robust genomic and proteomic testing capabilities across a variety of specimen types and high-throughput technologies.


Technologies (abbreviated list):

  • Dynamic Light Scattering (DLS)
  • Flow Cytometry
  • Fragment Analysis
  • Immunohistochemistry (IHC)
  • in situ Hybridization (ISH)
  • Laser Capture Microdissection
  • Mass Spectrometry
  • Next-Generation Sequencing
    • DNA and RNA
    • Somatic and Germline
    • Point Mutations, Indels, Fusions and Copy Number Variations
    • Hotspot, full Gene and Whole Exome
    • Sanger Sequencing
  • Pyro Sequencing
  • Quantitative Polymerase Chain Reaction (qPCR)
  • RT-PCR
  • Surface Plasma Resonance (SPR)


Annotated Biorepository Access:

  • Thousands of molecularly annotated samples with millions of slides
  • Climate controlled/monitored storage environments, including temperatures of 4°C, -20°C and -80°C
  • Processing and analysis
  • Reporting